Peptide-retargeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer.
暂无分享,去创建一个
M. Turunen | J. Koponen | S. Ylä-Herttuala | M. Hiltunen | A. Närvänen | O. Leppänen | A. Newby | J. Rutanen | H. Puhakka | A. Baker | Anna-Mari Turunen | A. Närvänen | Hanna L. Puhakka
[1] A. Herrmann,et al. Targeting of high-capacity adenoviral vectors. , 2001, Human gene therapy.
[2] Seppo Ylä-Herttuala,et al. Clinical applications of vascular gene therapy , 2001, Current cardiology reports.
[3] S. Borzak,et al. Treatment possibilities for unstable angina , 2000, BMJ : British Medical Journal.
[4] V. Kosma,et al. Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] J. Hartikainen,et al. Intravascular Adenovirus-Mediated VEGF-C Gene Transfer Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta , 2000, Circulation.
[6] S. Ylä-Herttuala,et al. Cardiovascular gene therapy , 2000, The Lancet.
[7] G. Pierce,et al. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors. , 2000, Human gene therapy.
[8] A. Houtsmuller,et al. Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers , 1999, Gene Therapy.
[9] Timo Sorsa,et al. Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.
[10] J. McEwan,et al. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. , 1999, Circulation.
[11] H. Ishibashi-Ueda,et al. Coronary atherosclerosis and interventions: Pathological sequences and restenosis , 1999, Pathology international.
[12] R. Crystal,et al. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. , 1999, The Journal of clinical investigation.
[13] F. Szoka,et al. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer–plasmid complexes , 1999, Gene Therapy.
[14] S. George. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. , 1998, Current opinion in lipidology.
[15] S. Ylä-Herttuala,et al. Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. , 1998, Human gene therapy.
[16] J. Hartikainen,et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. , 1998, Human gene therapy.
[17] G. Angelini,et al. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. , 1998, Human gene therapy.
[18] A. Baker,et al. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. , 1998, The Journal of clinical investigation.
[19] R. Assoian,et al. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. , 1996, The Journal of clinical investigation.
[20] J. Greene,et al. Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4* , 1996, The Journal of Biological Chemistry.
[21] J. Bittl,et al. Advances in coronary angioplasty. , 1996, The New England journal of medicine.
[22] A. Clowes,et al. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. , 1996, Circulation research.
[23] W. Stetler-Stevenson,et al. Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.
[24] N. Fineberg,et al. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. , 1995, Circulation.
[25] J. McEwan,et al. Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.
[26] M. Ferguson,et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. , 1995, Circulation.
[27] R. Califf. Restenosis: the cost to society. , 1995, American heart journal.
[28] P. Libby,et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[29] K Zatloukal,et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[30] F. Breedveld,et al. Methods for the detection of anti-endothelial antibodies by enzyme-linked immunosorbent assay. , 1991, Journal of immunological methods.
[31] Z. Werb,et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts , 1991, The Journal of cell biology.
[32] R. Hembry,et al. Metalloproteinases and tissue damage. , 1991, British journal of rheumatology.
[33] P W Serruys,et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. , 1988, Circulation.